Clinical Trial

Clinical Study on the Effects of Pulmonary Vessels on Cryoablation and Preventive Embolization Strategies

Not Yet Recruiting
View on ClinicalTrials.gov →
Summary
This study targeted high-risk individuals with incomplete ablation and performed selective pulmonary artery embolization before lung cryoablation, which could enhance the therapeutic effect and reduce the risk of intraoperative bleeding. Previous studies have shown that selective pulmonary artery embolization before ablation has no adverse reactions related to embolization. In this study, gelatin sponge particles were used for selective pulmonary artery embolization. Gelatin sponge is an absorbable embolic material that can be absorbed and degraded in the human body within about 7 days, which has high safety and a low probability of adverse reactions. The surgical risks are detailed in the surgical protocol. The study aims to optimize the lung cryoablation strategy for high-risk individuals with incomplete ablation, aiming to improve the prognosis of high-risk recurrent patients. The two groups of patients underwent lung CT reexamination every three months after surgery to observe the tumor ablation situation.
Trial Details
NCT Number NCT07594834
Lead Sponsor Haibo Shao
Conditions Lung Cancer
Enrollment 20 participants
Start Date 2026-06-30
Primary Completion 2027-06-30 (estimated)
Study Completion 2030-06-30 (estimated)
Updated on ClinicalTrials.gov 2026-05-19